Single-Exosome EpCAM Heterogeneity Profiling for Breast Cancer Diagnosis and Progression Monitoring
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c01556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Meihong Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical/Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha410082, China. Hauptthemen laut MEDLINE: Epithelial Cell Adhesion Molecule, Breast Neoplasms, Exosomes. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Science and Technology Project of Hunan, Science and Technology Project of Hunan Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Exosomes are nanoscale vesicles that are attractive for liquid biopsy, but most methods deliver ensemble averages and obscure how surface biomarkers vary across individual vesicles. We develop a single-particle impact electrochemistry (SPIE) assay to profile epithelial cell adhesion molecule (EpCAM) on single exosomes. EpCAM-positive vesicles are labeled with silver nanoparticle–aptamer conjugates. Each labeled exosome yields an silver oxidation spike upon collision with a polarized ultramicroelectrode. Impact frequency reports the abundance of EpCAM-positive exosomes, while the integrated spike charge provides a semiquantitative proxy for per-vesicle EpCAM. Using MCF-7 (EpCAM-high) and HeLa (EpCAM-low) exosomes, we confirm EpCAM-dependent signals and resolve intrapopulation heterogeneity. For serum samples from healthy donors and breast cancer patients at different clinical stages, SPIE reveals stage-dependent increases in both EpCAM-positive exosome counts and per-vesicle EpCAM load, consistent with nanoflow cytometry. This nonoptical platform enables semiquantitative single-exosome protein phenotyping in complex matrices, offering potential for disease-state-associated exosome analysis, clinical research, and future multiplexed profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical/Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha410082, China.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan410000, China.
ORCID-Profile: Yi-Ge Zhou
Förderung
- Science and Technology Project of Hunan
- Science and Technology Project of Hunan Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Peng, M., Xu, D., Zhang, Y., Shen, Q., Chen, J., & Zhou, Y. G. (2026). Single-Exosome EpCAM Heterogeneity Profiling for Breast Cancer Diagnosis and Progression Monitoring. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c01556
Vancouver
Peng M, Xu D, Zhang Y, Shen Q, Chen J, Zhou YG. Single-Exosome EpCAM Heterogeneity Profiling for Breast Cancer Diagnosis and Progression Monitoring. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c01556
BibTeX
@article{Peng2026,
author = {Peng, Meihong and Xu, Danping and Zhang, Yuanyuan and Shen, Qian and Chen, Jing and Zhou, Yi-Ge},
title = {Single-Exosome EpCAM Heterogeneity Profiling for Breast Cancer Diagnosis and Progression Monitoring},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c01556}
}
EUVIMED